DCN is a small leucine-rich proteoglycan acting as a powerful cancer repressor by blocking receptor tyrosine kinases [24], whose expression was decreased in HCC compared with normal liver tissues and followed the staging [25]. The gene discussed is NTRK1; the disease is hepatocellular carcinoma.